{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:26:46Z","timestamp":1773804406505,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd008717.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:00:00Z","timestamp":1580774400000}}],"reference-count":86,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008717.pub3","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T20:44:40Z","timestamp":1580849080000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Percutaneous ethanol injection for liver metastases"],"prefix":"10.1002","volume":"2020","author":[{"given":"Mateusz J","family":"Swierz","sequence":"first","affiliation":[{"name":"Jagiellonian University Medical College; Department of Hygiene and Dietetics, Systematic Reviews Unit; Krakow Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawid","family":"Storman","sequence":"additional","affiliation":[{"name":"University Hospital; Department of Hygiene and Dietetics, Systematic Reviews Unit, Jagiellonian University Medical College, Department of Adult Psychiatry; Krakow Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P","family":"Riemsma","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd; Unit 6, Escrick Business Park Riccall Road, Escrick York UK YO19 6FD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Wolff","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd; Unit 6, Escrick Business Park Riccall Road, Escrick York UK YO19 6FD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy W","family":"Mitus","sequence":"additional","affiliation":[{"name":"The Maria Sklodowska-Curie Institute, Oncology Center, Krakow Branch; Department of Anatomy, Jagiellonian University Medical College; Department of Surgical Oncology; ul. Garncarska 11 Krakow Poland 31-115"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Pedziwiatr","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College; 2nd Department of General Surgery; Jakubowskiego Street 2 Krakow Malopolska Poland 30-688"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos","family":"Kleijnen","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd; Unit 6, Escrick Business Park Riccall Road, Escrick York UK YO19 6FD"},{"name":"School for Public Health and Primary Care (CAPHRI), Maastricht University; Maastricht Netherlands 6200 MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata M","family":"Bala","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College; Chair of Epidemiology and Preventive Medicine, Department of Hygiene and Dietetics; Systematic Reviews Unit; Kopernika 7 Krakow Poland 31-034"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,2,4]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD008717.pub3-BIB0001|cit1","first-page":"49","article-title":"Transcatheter arterial chemoembolisation combined with CT guided percutaneous intratumor ethanol injection for liver metastases","volume":"4","author":"Liang","year":"2007","journal-title":"Chinese Journal of Interventional Imaging and Therapy"},{"issue":"2","key":"10.1002\/14651858.CD008717.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/02841868909111250","article-title":"Pharmacokinetics of intra-arterial mitomycin C with or without degradable starch microspheres (DSM) in the treatment of non-resectable liver cancer","volume":"28","author":"Andersson","year":"1989","journal-title":"Acta Oncologica"},{"issue":"1","key":"10.1002\/14651858.CD008717.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00270-010-9845-7","article-title":"Embolization of the gastroduodenal artery before selective internal radiotherapy: a prospectively randomized trial comparing standard pushable coils with fibered interlock detachable coils","volume":"34","author":"Dudeck","year":"2011","journal-title":"Cardiovascular and Interventional Radiology"},{"issue":"6","key":"10.1002\/14651858.CD008717.pub3-BIB0004|cit4","first-page":"853.e15","article-title":"Trans arterial hepatic embolization (TACE) adopting polyvinyl alcohol microspheres preloaded with irinotecan (DEBIRI) versus systemic therapy (FOLFIRI) for liver metastases (LM) from colorectal cancer (CRC): a randomized study of efficacy, toxicity and quality of life","volume":"23","author":"Fiorentini","year":"2012","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD008717.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/jco.2012.30.4_suppl.587","article-title":"Hepatic arterial embolization adopting polyvinyl alcohol microspheres preloaded with irinotecan versus systemic chemotherapy for hepatic metastases from colorectal cancer: a phase III clinical research trial of activity and quality of life","volume":"30","author":"Fiorentini","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008717.pub3-BIB0006|cit6","first-page":"15","article-title":"The ORCHESTRA trial: a phase III trial of adding tumor debulking to systemic therapy versus systemic therapy alone in (mCRC) multi-organ metastatic colorectal cancer","volume":"33","author":"Gootjes","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD008717.pub3-BIB0007|cit7","first-page":"406","article-title":"Locoregional versus systemic chemotherapy in metastatic colorectal cancer - efficacy of an additive immunotherapy with rubratin. A prospective randomized pilot study","volume":"14","author":"Holting","year":"1991","journal-title":"Onkologie"},{"issue":"6","key":"10.1002\/14651858.CD008717.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/1097-0142(19940915)74:6<1706::AID-CNCR2820740611>3.0.CO;2-J","article-title":"Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma","volume":"74","author":"Martinelli","year":"1994","journal-title":"Cancer"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD008717.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"TPS197","DOI":"10.1200\/jco.2010.28.15_suppl.tps197","article-title":"Yttrium microspheres with cetuximab plus irinotecan for patients with advanced colorectal cancer metastases to liver","volume":"28","author":"Murthy","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl","key":"10.1002\/14651858.CD008717.pub3-BIB0010|cit10","first-page":"18","article-title":"A phase III random assignment trial comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to standard of care for patients with hepatic metastases from metastatic ocular or cutaneous melanoma","volume":"28","author":"Pingpank","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl","key":"10.1002\/14651858.CD008717.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1200\/jco.2010.28.15_suppl.3559","article-title":"Unexpected increased biliary toxicity when systemic bevacizumab is added to hepatic arterial infusion","volume":"15","author":"Power","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD008717.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/1097-0142(19890715)64:2<379::AID-CNCR2820640207>3.0.CO;2-8","article-title":"Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial\/intravenous therapy). Results of a controlled clinical trial","volume":"64","author":"Safi","year":"1989","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0168-8278(02)80786-3","article-title":"Long term survival rates after transcatheter arterial chemoembolization (TACE) and percutaneous ethanol","volume":"36","author":"Soemarno","year":"2002","journal-title":"Journal of Hepatology"},{"issue":"9","key":"10.1002\/14651858.CD008717.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/1097-0142(19891101)64:9<1783::AID-CNCR2820640904>3.0.CO;2-Q","article-title":"Combined hepatic artery 5-fluorouracil and irradiation of liver metastases. A randomized study","volume":"64","author":"Wiley","year":"1989","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD008717.pub3-BIB0015|cit15","first-page":"142","article-title":"Effects of hepatic artery chemotherapeutic embolization combined with perfusing LAK cells into hepatic artery after radical operation of liver cancer","volume":"8","author":"Xie","year":"2000","journal-title":"Chung Hua Kan Tsang Ping Tsa Chih"},{"issue":"6","key":"10.1002\/14651858.CD008717.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archsurg.135.6.657","article-title":"Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm","volume":"135","author":"Bilchik","year":"2000","journal-title":"Archives of Surgery"},{"issue":"1","key":"10.1002\/14651858.CD008717.pub3-BIB0017|cit17","first-page":"5","article-title":"Evidence-based guideline on management of colorectal liver metastases in the Netherlands","volume":"65","author":"Bipat","year":"2007","journal-title":"Netherlands Journal of Medicine"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive - trial sequential analysis adjustment for random error risk in conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD008717.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1067\/j.cpsurg.2017.10.002","article-title":"Update on current problems in colorectal liver metastasis","volume":"54","author":"Chakedis","year":"2017","journal-title":"Current Problems in Surgery"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.291.20.2457","article-title":"Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles","volume":"291","author":"Chan","year":"2004","journal-title":"JAMA"},{"issue":"10125","key":"10.1002\/14651858.CD008717.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S1470-2045(04)01567-0","article-title":"Radiofrequency ablation of liver tumours: systematic review","volume":"5","author":"Decadt","year":"2004","journal-title":"Lancet Oncology"},{"issue":"3","key":"10.1002\/14651858.CD008717.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0029|cit29","unstructured":"Ferlay J Ervik M Lam F Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2018 gco.iarc.fr\/today\/data\/factsheets\/cancers\/10_8_9-Colorectum-fact-sheet.pdf"},{"issue":"4","key":"10.1002\/14651858.CD008717.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study","volume":"3","author":"Global Burden of Disease Cancer Collaboration","year":"2017","journal-title":"JAMA Oncology"},{"issue":"3","key":"10.1002\/14651858.CD008717.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7326\/0003-4819-149-3-200808050-00023","article-title":"Correction: reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"149","author":"Gluud","year":"2008","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0032|cit32","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2307\/2530643","article-title":"Estimation of a common effect parameter from sparse follow-up data","volume":"41","author":"Greenland","year":"1985","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0034|cit34","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011) The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"15","key":"10.1002\/14651858.CD008717.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.ejca.2015.07.024","article-title":"On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007 - results from the EUROCARE-5 study","volume":"51","author":"Holleczek","year":"2015","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0036|cit36","unstructured":"Howlader N Noone AM Krapcho M Miller D Brest A Yu M SEER Cancer Statistics Review, 1975-2016, 2018 seer.cancer.gov\/csr\/1975_2015\/"},{"issue":"4","key":"10.1002\/14651858.CD008717.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1503\/cmaj.120744","article-title":"Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors","volume":"185","author":"Hrobjartsson","year":"2013","journal-title":"Canadian Medical Association Journal"},{"issue":"4","key":"10.1002\/14651858.CD008717.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ije\/dyu115","article-title":"Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies","volume":"43","author":"Hrobjartsson","year":"2014","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD008717.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/ije\/dyt270","article-title":"Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors","volume":"43","author":"Hrobjartsson","year":"2014","journal-title":"International Journal of Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD008717.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1445-2197.1997.tb02003.x","article-title":"The aetiology and management of hepatic metastases","volume":"67","author":"Hugh","year":"1997","journal-title":"Australian and New Zealand Journal of Surgery"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0041|cit41","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"5","key":"10.1002\/14651858.CD008717.pub3-BIB0042|cit42","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"3","key":"10.1002\/14651858.CD008717.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/jcm8030403","article-title":"Treatment of liver metastases from midgut neuroendocrine tumours: a systematic review and meta-analysis","volume":"8","author":"Kacmaz","year":"2019","journal-title":"Journal of Clinical Medicine"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD008717.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/02656736.2016.1237681","article-title":"Radiofrequency ablation combined with percutaneous ethanol injection for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"33","author":"Li","year":"2017","journal-title":"International Journal of Hyperthermia"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"3","key":"10.1002\/14651858.CD008717.pub3-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"e000315","DOI":"10.1136\/esmoopen-2017-000315","article-title":"Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San Jos\u00e9, Costa Rica, August 2016","volume":"3","author":"L\u00f3pez","year":"2018","journal-title":"ESMO Open"},{"issue":"7","key":"10.1002\/14651858.CD008717.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18070","article-title":"The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation","volume":"18","author":"Loveman","year":"2014","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0049|cit49","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0050|cit50","unstructured":"Marlow NE A systematic review of radiofrequency ablation for the treatment of liver tumours (update) ASERNIP-S report no. 56 www.surgeons.org\/media\/17297\/RFAupdate.pdf"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial","volume":"14","author":"Nordlinger","year":"2013","journal-title":"Lancet Oncology"},{"issue":"5","key":"10.1002\/14651858.CD008717.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/hep.510230509","article-title":"Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases","volume":"23","author":"Ohnishi","year":"1996","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1002\/14651858.CD008717.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hep.510270112","article-title":"Prospective randomized controlled trial comparing percutaneous acetic acid and percutaneous ethanol injection for small hepatocellular carcinoma","volume":"27","author":"Ohnishi","year":"1998","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"10.1002\/14651858.CD008717.pub3-BIB0055|cit55","first-page":"74","article-title":"Global Cancer Statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"12","key":"10.1002\/14651858.CD008717.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1763-72","DOI":"10.1007\/s00432-011-1026-9","article-title":"Interventional therapies of unresectable liver metastases","volume":"137","author":"Qian","year":"2011","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD008717.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"181-92","DOI":"10.1016\/j.rpor.2017.02.007","article-title":"Other non-surgical treatments for liver cancer","volume":"22","author":"Revel-Mouroz","year":"2017","journal-title":"Reports of Practical Oncology and Radiotherapy"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0059|cit59","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0060|cit60","unstructured":"Riemsma R Bala M Wolff R Kleijnen J Non-surgical ablation methods for primary malignant liver tumours and liver metastases www.zorginstituutnederland.nl\/publicaties\/standpunten\/2009\/05\/19\/verschillende-niet-chirurgische-locoregionale-interventies-bij-levertumoren-zijn-een-te-verzekeren-prestatie-rfa-nog-niet 1 271"},{"issue":"4","key":"10.1002\/14651858.CD008717.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"35","key":"10.1002\/14651858.CD008717.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD008717.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD008717.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in Cochrane Reviews: the ROBES Meta-Epidemiologic Study","volume":"187","author":"Savovi\u0107","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD008717.pub3-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006745.pub2","article-title":"Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma","author":"Schoppmeyer","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD008717.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0067|cit67","first-page":"7","article-title":"Cancer statistics 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"7","key":"10.1002\/14651858.CD008717.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1010428317714626","article-title":"Progress in the treatment of advanced gastric cancer","volume":"39","author":"Song","year":"2017","journal-title":"Tumour Biology"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 Statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0070|cit70","first-page":"e7586","article-title":"SPIRIT 2013 Explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"5","key":"10.1002\/14651858.CD008717.pub3-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012069.pub2","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies","author":"Storeb\u00f8","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2046-4053-3-54","article-title":"Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram","volume":"3","author":"Stovold","year":"2014","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archsurg.141.2.181","article-title":"Radiofrequency ablation of liver tumors. A systematic review","volume":"141","author":"Sutherland","year":"2006","journal-title":"Archives of Surgery"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0075|cit75","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0076|cit76","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-24223-1_1","article-title":"Lung cancer statistics","volume":"893","author":"Torre","year":"2016","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0079|cit79","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis 2011"},{"issue":"1","key":"10.1002\/14651858.CD008717.pub3-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006745.pub3","article-title":"Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma","author":"Weis","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008717.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008717.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in a random-effects meta-analysis","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD008717.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"issue":"7644","key":"10.1002\/14651858.CD008717.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"5","key":"10.1002\/14651858.CD008717.pub3-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008717.pub2","article-title":"Percutaneous ethanol injection for liver metastases","author":"Riemsma","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD008717.pub3-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008717","article-title":"Percutaneous ethanol injection for liver metastases","author":"Riemsma","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD008717.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T08:18:31Z","timestamp":1637396311000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008717.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,4]]},"references-count":86,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008717.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,4]]}}}